Financial
Latest full-year results from official filings.
Listed (300676.SZ).
Latest full-year results not yet captured by HSH.
BGI Genomics: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Researched 8 Nov 2026
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Oct 2026: the US Department of Homeland Security added BGI Genomics to the Uyghur Forced Labor Prevention Act Entity List, banning imports, alleging it helped collect genetic material used to track persecuted minorities; BGI denies the allegations.
- US bans imports from BGI Genomics, MGI Tech citing ties to forced labor in Xinjiang · American Journal of Transportation (AJOT) · 28 Oct 2026
- US bans imports from Chinese genomics firms (AFP) · Taipei Times · 30 Oct 2026
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
Oct 2026: in its import ban, US DHS alleged BGI companies helped collect genetic material used to track ethnic minorities, which China and BGI deny. No confirmed data breach involving BGI Genomics found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
- US bans imports from Chinese genomics firms (AFP) · Taipei Times · 30 Oct 2026
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
Dec 2025: the US BIOSECURE Act became law, restricting US federal contracts and grants involving 'biotechnology companies of concern'; legal commentary identifies BGI as covered via the Pentagon's 1260H list. No product recalls or safety notices found.
- BIOSECURE Act becomes law limiting grants with biotechnology companies of concern · Latham & Watkins · 31 Dec 2025
Contract performance
Contract delivery, go-lives, terminations and disputes.
No notable contract go-lives, terminations or customer disputes involving BGI Genomics found in HSH's search of the last 24 months.